Matrai C, Motanagh S, Mirabelli S, Ma L, He B, Chapman-Davis E, Kurtis B, Elemento O, Mosquera JMiguel, Ellenson LH.
2020.
Molecular Profiles of Mixed Endometrial Carcinoma.. Am J Surg Pathol. 44(8):1104-1111.
Fulmer CG, Park K, Dilcher T, Ho M, Mirabelli S, Alperstein S, Hissong EM, Pittman M, Siddiqui M, Heymann JJ et al..
2020.
Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study.. Cancer Cytopathol. 128(11):840-851.
Buqué A, Bloy N, Petroni G, Kroemer G, Galluzzi L.
2020.
NK cells beat T cells at early breast cancer control.. Oncoimmunology. 9(1):1806010.
Chong SJun Fei, Marchi S, Petroni G, Kroemer G, Galluzzi L, Pervaiz S.
2020.
Noncanonical Cell Fate Regulation by Bcl-2 Proteins.. Trends Cell Biol. 30(7):537-555.
Fragliasso V, Verma A, Manzotti G, Tameni A, Bareja R, Heavican TB, Iqbal J, Wang R, Fiore D, Mularoni V et al..
2020.
The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK anaplastic large cell lymphoma by regulating the DNA helicase HELLS.. Leukemia. 34(11):2964-2980.
Kumar S, Warrell J, Li S, McGillivray PD, Meyerson W, Salichos L, Harmanci A, Martinez-Fundichely A, W Y Chan C, Nielsen MMuhlig et al..
2020.
Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences.. Cell. 180(5):915-927.e16.
Park K, Tran H, Eng KW, Ramazanoglu S, Rolon RMMarrero, Scognamiglio T, Borczuk A, Mosquera JMiguel, Pan Q, Sboner A et al..
2020.
Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.. Arch Pathol Lab Med. 144(12):1535-1546.
Mondanelli G, Coletti A, Greco FAntonio, Pallotta MTeresa, Orabona C, Iacono A, Belladonna MLaura, Albini E, Panfili E, Fallarino F et al..
2020.
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation.. Proc Natl Acad Sci U S A. 117(7):3848-3857.
Heymann JJ, Yoxtheimer LM, Park HJin, Fernandez EM, Facey KE, Alperstein SA, Tran HV, Baek I, Scognamiglio T, Rennert H et al..
2020.
Preanalytic variables in quality and quantity of nucleic acids extracted from FNA specimens of thyroid gland nodules collected in CytoLyt: Cellularity and storage time.. Cancer Cytopathol. 128(9):656-672.
Curchoe CLynn, Malmsten J, Bormann C, Shafiee H, Farias AFlores-Sai, Mendizabal G, Chavez-Badiola A, Sigaras A, Alshubbar H, Chambost J et al..
2020.
Predictive modeling in reproductive medicine: Where will the future of artificial intelligence research take us? Fertil Steril. 114(5):934-940.
Fizazi K, Kramer G, Eymard J-C, Sternberg CN, de Bono J, Castellano D, Tombal B, Wülfing C, Liontos M, Carles J et al..
2020.
Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study.. Lancet Oncol. 21(11):1513-1525.
Sternberg CN, Saad F, Graff JN, Peer A, Vaishampayan UN, Leung E, Rosenbaum E, Gurney H, Epstein RJ, Davis ID et al..
2020.
A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer.. Ann Oncol. 31(2):257-265.
Abida W, Patnaik A, Campbell D, Shapiro J, Bryce AH, McDermott R, Sautois B, Vogelzang NJ, Bambury RM, Voog E et al..
2020.
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a or Gene Alteration.. J Clin Oncol. 38(32):3763-3772.
Rimel JK, Poss ZC, Erickson B, Maas ZL, Ebmeier CC, Johnson JL, Decker T-M, Yaron TM, Bradley MJ, Hamman KB et al..
2020.
Selective inhibition of CDK7 reveals high-confidence targets and new models for TFIIH function in transcription.. Genes Dev. 34(21-22):1452-1473.